Target intelligence / Profile preview

Poliovirus type 3 capsid protein VP1 (VP1)

Target
VP1
Molecular classification
Viral capsid protein
01

Overview

The poliovirus type 3 capsid protein VP1 is a major structural component of the viral icosahedral capsid, which consists of 60 copies each of VP1, VP2, VP3, and VP4. VP1 features an eight-stranded antiparallel beta-barrel core decorated with loops and extensions that contribute to the canyon surrounding the fivefold axis on the capsid surface, where the poliovirus receptor (PVR) binds by inserting its domain 1 into this depression.[1][8] This interaction triggers conformational changes leading to the 135S particle intermediate, externalizing the N-terminus of VP1 and VP4 to facilitate membrane insertion and viral RNA release during cell entry.[2][3] The N-terminal extension of VP1, predicted to form an amphipathic helix, associates with host cell membranes, potentially forming a translocation pore for the genome.[2][3] A hydrophobic pocket within VP1's core often contains a "pocket factor" that stabilizes the capsid, and mutations in VP1 loops can alter receptor usage, stability, or drug resistance.[1][3] VP1 plays a critical role in poliovirus pathogenesis by enabling infection of motor neurons, leading to poliomyelitis.[4] Although no small-molecule drugs directly target VP1 clinically, its structure has informed antiviral strategies like pocket-binding compounds in related enteroviruses.[3]

Other names
Poliovirus capsid protein VP1PV VP1
02

Biological functions

Capsid structure and stabilityReceptor bindingCell entry and uncoatingViral RNA protection
03

Disease associations

Poliovirus infection

Beyond the preview

Go deeper on Poliovirus type 3 capsid protein VP1 (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus type 3 capsid protein VP1 (VP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call